Literature DB >> 12837830

Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation.

Hester M Klaren1, Laura J van't Veer, Flora E van Leeuwen, Matti A Rookus.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12837830     DOI： 10.1093/jnci/95.13.941

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

1.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Authors:  Mary S Beattie; Beth Crawford; Feng Lin; Eric Vittinghoff; John Ziegler
Journal:  Genet Test Mol Biomarkers       Date:  2009-02

2.  Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.

Authors:  Tehillah S Menes; Mary Beth Terry; David Goldgar; Irene L Andrulis; Julia A Knight; Esther M John; Yuyan Liao; Melissa Southey; Alexander Miron; Wendy Chung; Saundra S Buys
Journal:  Breast Cancer Res Treat       Date:  2015-05-15       Impact factor: 4.872

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.

Authors:  Kelly-Anne Phillips; Phyllis N Butow; Ailsa E Stewart; Jiun-Horng Chang; Prue C Weideman; Melanie A Price; Sue Anne McLachlan; Geoffrey J Lindeman; Michael J McKay; Michael L Friedlander; John L Hopper
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.

Authors:  Susan M Domchek; Tara M Friebel; Judy E Garber; Claudine Isaacs; Ellen Matloff; Rosalind Eeles; D Gareth Evans; Wendy Rubinstein; Christian F Singer; Stephen Rubin; Henry T Lynch; Mary B Daly; Jeffrey Weitzel; Patricia A Ganz; Gabriella Pichert; Olufunmilayo I Olopade; Gail Tomlinson; Nadine Tung; Joanne L Blum; Fergus Couch; Timothy R Rebbeck
Journal:  Breast Cancer Res Treat       Date:  2010-02-24       Impact factor: 4.872

6.  Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.

Authors:  Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Richard Holubkov; Lindsey Bloor; Ken Smith
Journal:  J Genet Couns       Date:  2006-08       Impact factor: 2.537

7.  Risk of de novo cancer after premenopausal bilateral oophorectomy.

Authors:  Nan Huo; Carin Y Smith; Liliana Gazzuola Rocca; Walter A Rocca; Michelle M Mielke
Journal:  Am J Obstet Gynecol       Date:  2021-11-10       Impact factor: 8.661

8.  Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.

Authors:  P Shah; M Rosen; J Stopfer; J Siegfried; R Kaltman; B Mason; K Armstrong; K L Nathanson; M Schnall; S M Domchek
Journal:  Breast Cancer Res Treat       Date:  2009-07-17       Impact factor: 4.872

9.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

Review 10.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.